A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Investigational New Drugs.
Times cited: 4
Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
Journal of Clinical Oncology.
Times cited: 60